Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP142) in the absence of an affinity tag

Protein Expression and Purification

Volumn 50, Issue 1, 2006, Pages 58-67

  Shimp Jr , Richard L ^a   Martin, Laura B ^a   Zhang, Yanling ^a   Henderson, Brian S ^a   Duggan, Peter ^a   MacDonald, Nicholas J ^a   Lebowitz, Jacob ^a   Saul, Allan ^a   Narum, David L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Escherichia coli; MSP1; Plasmodium falciparum; Refold; Vaccine

Indexed keywords

MEROZOITE SURFACE PROTEIN 1; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; BIOSYNTHESIS; ESCHERICHIA COLI; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; ISOLATION AND PURIFICATION; MOLECULAR CLONING; MOLECULAR WEIGHT; PLASMODIUM FALCIPARUM; PROTEIN FOLDING; SENSITIVITY AND SPECIFICITY; SOLUBILITY; TIME;

ANIMALS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLONING, MOLECULAR; ESCHERICHIA COLI; HYDROPHOBICITY; MEROZOITE SURFACE PROTEIN 1; MOLECULAR WEIGHT; PLASMODIUM FALCIPARUM; PROTEIN FOLDING; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SOLUBILITY; TIME FACTORS;

ANIMALIA; ESCHERICHIA COLI; PICHIA PASTORIS; PLASMODIUM FALCIPARUM; SACCHAROMYCES CEREVISIAE;

EID: 33751046331     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.06.018     Document Type: Article

References (30)

1. McBride J.S., and Heidrich H.G. Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol. 23 (1987) 71-84
2. Blackman M.J., Whittle H., and Holder A.A. Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol. Biochem. Parasitol. 49 (1991) 35-44
3. Miller L.H., Roberts T., Shahabuddin M., and McCutchan T.F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 59 (1993) 1-14
4. Tanabe K., Mackay M., Goman M., and Scaife J.G. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 195 (1987) 273-287
5. Darko C.A., Angov E., Collins W.E., Bergmann-Leitner E.S., Girouard A.S., Hitt S.L., McBride J.S., Diggs C.L., Holder A.A., Long C.A., Barnwell J.W., and Lyon J.A. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect. Immun. 73 (2005) 287-297
6. Singh S., Kennedy M.C., Long C.A., Saul A.J., Miller L.H., and Stowers A.W. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1. Infect. Immun. 71 (2003) 6766-6774
7. Stowers A.W., Cioce V., Shimp R.L., Lawson M., Hui G., Muratova O., Kaslow D.C., Robinson R., Long C.A., and Miller L.H. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial. Infect. Immun. 69 (2001) 1536-1546
8. Renia L., Ling I.T., Marusing M., Miltgen F., Holder A.A., and Mazier D. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge. Infect. Immun. 65 (1997) 4419-4423
9. Stowers A.W., Kennedy M.C., Keegan B.P., Saul A., Long C.A., and Miller L.H. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. Infect. Immun. 70 (2002) 6961-6967
10. Ockenhouse C.F., Angov E., Kester K.E., Diggs C., Soisson L., Cummings J.F., Stewart A.F., Palmer D.R., Mahajan B., Krzych U., Tornieporth N., Delchambre M., Vanhandenhove M., Ofori-Anyinam O., Cohen J., Lyon J.A., and Heppner D.G. Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. Vaccine 24 (2006) 3009-3017
11. Dutta D., Kaushal D.C., Ware L.A., Puri S.K., Kaushal N.A., Narula A., Upadhyaya D.S., and Lanar D.E. Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys. Infect. Immun. 73 (2005) 5936-5944
12. Egan A.F., Morris J., Barnish G., Saul A., Greenwood B.M., Kaslow D.C., Holder A.A., and Riley E.M. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen PfMSP-1. J. Infect. Dis. 173 (1996) 765-769
13. Chang S.P., Kramer K.J., Yamaga K.M., Kato A., Case S.E., and Siddiqui W.A. Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate. Exp. Parasitol. 67 (1988) 1-11
14. Conway D.J., Cavanagh D.R., Tanabe K., Roper C., Mikes Z.S., Sakihama N., Bojang K.A., Oduola A.M., Kremsner P.G., Arnot D.E., Greenwood B.M., and McBride J.S. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 6 (2000) 689-692
15. Angov E., Aufiero B.M., Turgeon A.M., Van Handenhove M., Ockenhouse C.F., Kester K.E., Walsh D.S., McBride J.S., Dubois M.C., Cohen J., Haynes J.D., Eckels K.H., Heppner D.G., Ballou W.R., Diggs C.L., and Lyon J.A. Development and pre-clinical analysis of a Plasmodium falciparum merozoite surface protein-1(42) malaria vaccine. Mol. Biochem. Parasitol. 128 (2003) 195-204
16. J.A. Stoute, J. Gombe, M.R. Withers, J. Siangla, D. McKinney, M. Onyango, J.F. Cummings, J. Milman, K. Tucker, L. Soisson,V.A. Stewart, J.A. Lyon, E. Angov, A. Leach, J. Cohen, K.E. Kester, C.F. Ochenhouse, C.A. Holland, C.L. Diggs, J. Wittes, D.G. Heppner Jr., Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya', Vaccine (2006), in press, doi:10.1016/J.Vaccine.2005.11.037.
17. Brady C.P., Shimp R.L., Miles A.P., Whitmore M., and Stowers A.W. High-level production and purification of P30P2MSP1(19), an important vaccine antigen for malaria, expressed in the methylotropic yeast Pichia pastoris. Protein Expr. Purif. 23 (2001) 468-475
18. Folta-Stogniew E., and Williams K.R. Determination of molecular masses of proteins in solution: implementation of an HPLC size exclusion chromatography and laser light scattering service in a core laboratory. J. Biomol. Tech. 10 (1999) 51-63
19. Schuck P., Perugini M.A., Gonzales N.R., Howlett G.J., and Schubert D. size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys. J. 82 (2002) 1096-1111
20. Lebowitz J., Lewis M.S., and Schuck P. Modern analytical ultracentrifugation in protein science: a tutorial review. Protein Sci. 11 (2002) 2067-2079
21. Tsai C.W., Duggan P.F., Shimp Jr. R.L., Miller L.H., and Narum D.L. Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris. J. Biotechnol. 121 (2006) 458-470
22. Richards G.P., Hammer C.H., Garfield M.K., and Parveen S. Characterization of a lysyl aminopeptidase activity associated with phosphoglucose isomerase of Vibrio vulnificus. Biochim. Biophys. Acta 1700 (2004) 219-229
23. Levin J., and Bang F.B. The role of endotoxin in the extracellular coagulation of limulus blood. Bull. Johns Hopkins Hosp. 115 (1964) 265-274
24. Cooper J.F., Hochstein H.D., and Seligmann Jr. E.B. The Limulus test for endotoxin (Pyrogen) in radiopharmaceuticals and biologicals. Bull. Parenter Drug Assoc. 26 (1972) 153-162
25. Miles A.P., Zhu D., and Saul A.J. Determining residual host cell antigen levels in purified recombinant proteins by slot blot and scanning laser densitometry. Methods Mol. Biol. 308 (2005) 233-242
26. Zhu D., Saul A.J., and Miles A.P. A quantitative slot blot assay for host cell protein impurities in recombinant protein expressed in E. coli. JIM 306 (2005) 40-50
27. Chappel J.A., and Holder A.A. Monoclonal antibodies inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol. 60 (2003) 303-312
28. Uthaipibull C., Aufiero B., Syed S.E., Hansen B., Guevara Patino J.A., Angov E., Ling I.T., Fegeding K., Morgan W.D., Ockenhouse C., Birdsall B., Feeney J., Lyon J.A., and Holder A.A. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 307 (2001) 1381-1394
29. Mazel D., Pochet S., and Marliere P. Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation. EMBO J. 13 (1994) 914-923
30. Vistica J., Dam J., Balbo A., Yikilmaz E., Mariuzza R.A., Rouault T.A., and Schuck P. Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition. Anal. Biochem. 326 (2004) 234-256